Crinetics Pharmaceuticals, Inc. (CRNX) earnings
Quarterly results of Crinetics Pharmaceuticals, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Crinetics Pharmaceuticals, Inc. was expected to report around October 12, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Crinetics Pharmaceuticals, Inc. reported revenue of $25.1M (+2,336.3% on the same quarter a year earlier) and a net loss of $120.9M.
Diluted earnings per share were -$1.14.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $25.1M | +2,336.3% | -$120.9M | -$1.14 |
| Q1 FY2026 | $10.7M | +2,873.4% | -$127.8M | -$1.23 |
| Q4 FY2025 | $6.2M | - | -$122.8M | - |
| Q3 FY2025 | $143K | - | -$130.1M | -$1.38 |
| Q2 FY2025 | $1M | - | -$115.6M | -$1.23 |
| Q1 FY2025 | $361K | - | -$96.8M | -$1.04 |
| Q4 FY2024 | $0 | - | -$80.6M | - |
| Q3 FY2024 | $0 | - | -$76.8M | -$0.96 |
Results filings
- Quarterly report 10-Q
When is Crinetics Pharmaceuticals, Inc.'s next earnings date?
Crinetics Pharmaceuticals, Inc. was expected to report around October 12, 2026; nothing is on file with the SEC yet.
What were Crinetics Pharmaceuticals, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Crinetics Pharmaceuticals, Inc. reported revenue of $25.1M and a net loss of $120.9M. The figures come from its filing with the SEC.
Is Crinetics Pharmaceuticals, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $25.1M, up 2,336.3% from $1M in the same quarter a year earlier.
Get an email when CRNX reports
Follow CRNX and we email you its next results the day they are filed, with the numbers explained.